A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Weill Medical College of Cornell University
Tango Therapeutics, Inc.
AstraZeneca
Cedars-Sinai Medical Center
Hoffmann-La Roche
Dartmouth-Hitchcock Medical Center
Merck Sharp & Dohme LLC
BioInvent International AB
University of Cincinnati
Seagen Inc.
Mayo Clinic
Anaveon AG
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ascendis Pharma A/S
Merck Sharp & Dohme LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Genmab
Merck Sharp & Dohme LLC
Takeda
Astellas Pharma Inc
Eikon Therapeutics
Genmab
Genmab
Tvardi Therapeutics, Incorporated
Mayo Clinic
ModernaTX, Inc.
Servier
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Weill Medical College of Cornell University
University of Iowa
Merck Sharp & Dohme LLC
Astellas Pharma Inc
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Synthekine
Shionogi Inc.
GI Innovation, Inc.
Bristol-Myers Squibb
Merck Sharp & Dohme LLC